Your browser doesn't support javascript.
loading
Cost-effectiveness of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris.
Mavranezouli, Ifigeneia; Welton, Nicky J; Daly, Caitlin H; Wilcock, Jane; Bromham, Nathan; Berg, Laura; Xu, Jingyuan; Wood, Damian; Ravenscroft, Jane C; Dworzynski, Katharina; Healy, Eugene.
Afiliação
  • Mavranezouli I; Centre for Outcomes Research and Effectiveness, Research Department of Clinical, Educational and Health Psychology, University College London, London, UK.
  • Welton NJ; National Guideline Alliance, Royal College of Obstetricians and Gynaecologists, London, UK.
  • Daly CH; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Wilcock J; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Bromham N; Silverdale Medical Practice, Pendlebury Health Centre, Salford, UK.
  • Berg L; National Guideline Alliance, Royal College of Obstetricians and Gynaecologists, London, UK.
  • Xu J; National Institute for Health and Care Excellence, Manchester, UK.
  • Wood D; National Guideline Alliance, Royal College of Obstetricians and Gynaecologists, London, UK.
  • Ravenscroft JC; National Institute for Health and Care Excellence, Manchester, UK.
  • Dworzynski K; National Guideline Alliance, Royal College of Obstetricians and Gynaecologists, London, UK.
  • Healy E; Department of Dermatopharmacology, University of Manchester, Manchester, UK.
Clin Exp Dermatol ; 47(12): 2176-2187, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36258288
ABSTRACT

BACKGROUND:

Acne vulgaris is a common skin condition that may cause psychosocial distress. There is evidence that topical treatment combinations, chemical peels and photochemical therapy (combined blue/red light) are effective for mild-to-moderate acne, while topical treatment combinations, oral antibiotics combined with topical treatments, oral isotretinoin and photodynamic therapy are most effective for moderate-to-severe acne. Effective treatments have varying costs. The National Institute for Health and Care Excellence (NICE) in England considers cost-effectiveness when producing national clinical, public health and social care guidance.

AIM:

To assess the cost-effectiveness of treatments for mild-to-moderate and moderate-to-severe acne to inform relevant NICE guidance.

METHODS:

A decision-analytical model compared costs and quality-adjusted life-years (QALYs) of effective topical pharmacological, oral pharmacological, physical and combined treatments for mild-to-moderate and moderate-to-severe acne, from the perspective of the National Health Service in England. Effectiveness data were derived from a network meta-analysis. Other model input parameters were based on published sources, supplemented by expert opinion.

RESULTS:

All of the assessed treatments were more cost-effective than treatment with placebo (general practitioner visits without active treatment). For mild-to-moderate acne, topical treatment combinations and photochemical therapy (combined blue/red light) were most cost-effective. For moderate-to-severe acne, topical treatment combinations, oral antibiotics combined with topical treatments, and oral isotretinoin were the most cost-effective. Results showed uncertainty, as reflected in the wide confidence intervals around mean treatment rankings.

CONCLUSION:

A range of treatments are cost-effective for the management of acne. Well-conducted studies are needed to examine the long-term clinical efficacy and cost-effectiveness of the full range of acne treatments.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isotretinoína / Acne Vulgar Tipo de estudo: Clinical_trials / Guideline / Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isotretinoína / Acne Vulgar Tipo de estudo: Clinical_trials / Guideline / Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article